Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 364

The DOI matches its Crossref record.

Tachykinin antagonists

· 1994 · Expert Opinion on Therapeutic Patents

Abstract

The discovery of nonpeptide antagonists of the tachykinin peptides substance P, neurokinin A, and neurokinin B has greatly accelerated pharmacological characterization of the role of these peptides and their receptors (NK-1, NK-2, and NK-3) in the central nervous system (CNS). The extensive structural diversity of the nonpeptide tachykinin antagonists offers considerable potential for therapeutic agents targeting this system, and includes NK-1 antagonists such as: I. the quinuclidine amines (CP-96,345) and related ethers, 2. the piperidine amines (CP-99,994) and related ethers and acyclic variants, 3. the isoindolines such as RP 67,580 and RPR 100,893, 4. the 2-benzylpiperidines CGP-47,899 and CGP 49,823, 5. the peptide-derived FK-888, and 6. SR-140,333, as well as NK-2 antagonists such as SR-48,968, and GR-159,897, and NK-3 antagonists such as PD- 157,652 and SR-142,801. Important new pharmacological insights facilitated by these compounds indicate a role for tachykinin peptides in control of dopamine function in the CNS, emesis, pain, and neurogenic inflammation. These compounds have also enabled characterization of the nonpeptide antagonist binding site on the NK-1 receptor, providing insight on the mechanism of receptor antagonism to help in the design of new compounds. Hence the nonpeptide tachykinin antagonists continue to play an important role in characterizing biochemical, pharmacological, and potential therapeutic aspects of the tachykinin peptides.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1517/13543776.4.7.859

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 364

Metadata

Venue
Expert Opinion on Therapeutic Patents
Published
1994-07
Volume
4
Issue
7
Pages
859-860
ISSN
  • 1354-3776 (ISSN-L)
  • 1744-7674
OpenAlex
W4235222786
Cited by
364
References
0
FWCI
5.61
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Tachykinin antagonists. https://app.cochat.ai/papers/10.1517/13543776.4.7.859
The paper
Tachykinin antagonists. (1994). Expert Opinion on Therapeutic Patents. https://doi.org/10.1517/13543776.4.7.859

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.